Remove patient-hubs-continue-growth
article thumbnail

Patient Hubs Continue Growth

PharmExec

How technology will play a big role in advancing pharma approaches in patient support.

article thumbnail

Fosun Pharma and IFC to build new drug manufacturing plant in Africa

Pharmaceutical Technology

Shanghai Fosun Pharmaceutical (Group) is to collaborate with the International Finance Corporation (IFC) to construct a new pharmaceutical production facility and distribution hub near Abidjan, Côte d’Ivoire. The IFC will provide two loans totalling $53.49m (€50m) to Fosun Pharma’s subsidiaries.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AstraZeneca to manufacture pharmaceuticals in Abu Dhabi

European Pharmaceutical Review

The agreement focuses on collaboration in four key areas including localising innovative industries, R&D , innovation and sustainability at a global scale to enhance the United Arab Emirates (UAE’s) position as a global hub for future industries.

article thumbnail

Influencer marketing in pharma

World of DTC Marketing

Scandals, fake followers, bot technologies, and the pandemic crisis converged have put a halt to influencer marketing growth and tarnished the public view of influencers as a whole. bil­lion in 2020, ac­cord­ing to In­flu­encer Mar­ket­ing Hub , which es­ti­mat­ed the mar­ket would grow to $13.8 bil­lion in 2021.

Marketing 192
article thumbnail

Alexion to expand biologics manufacturing with €65m investment

European Pharmaceutical Review

Marc Dunoyer, Chief Executive Officer (CEO) of Alexion, stated “We are delighted to be further investing in our facilities in Ireland, an increasingly critical global hub for AstraZeneca operations, to support the continued growth of Alexion’s portfolio of medicines and meet our needs for expansion.

article thumbnail

Specialty Treatments Require a New Approach to Affordability

PM360

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. 1 We have been improving patient affordability for over a decade, across generic and brand medications, including specialty treatments—sometimes by more than 50%.

article thumbnail

Access solutions: the missing link that prevents biopharma innovation from reaching patients

pharmaphorum

We live in unprecedented times, where innovation in biosciences continues to accelerate. Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need. Why current patient access solutions have come up short. Why current patient access solutions have come up short.